Notable Analyst Upgrades and Downgrades for Week of September 13, 2021



 

Upgrades:

 


Bank of America (NYSE:BAC) was upgraded by stock analysts at Odeon Capital Group from a "hold" rating to a "buy" rating in a research report issued on Monday, The Fly reports. The brokerage presently has a $46.50 price target on the financial services provider's stock. Odeon Capital Group's price target indicates a potential upside of 15.47% from the stock's previous close.

Several other equities research analysts have also commented on the company. Evercore ISI restated a "buy" rating and issued a $43.00 price objective on shares of Bank of America in a research note on Friday, July 2nd. Truist Securities started coverage on Bank of America in a research note on Wednesday, June 2nd. They issued a "buy" rating for the company. Royal Bank of Canada set a $37.69 price objective on Bank of America and gave the stock a "buy" rating in a research note on Wednesday, July 21st. Credit Suisse Group upped their price objective on Bank of America from $46.00 to $47.00 and gave the stock an "outperform" rating in a research note on Friday, July 16th. Finally, Morgan Stanley upped their price objective on Bank of America from $38.00 to $42.00 and gave the stock an "underweight" rating in a research note on Thursday, July 29th. One analyst has rated the stock with a sell rating, five have assigned a hold rating and fifteen have given a buy rating to the company. Based on data from MarketBeat.com, the company has a consensus rating of "Buy" and an average price target of $40.42. Read more …

 


Baxter International (NYSE:BAX) was upgraded by research analysts at Cowen from a “market perform” rating to an “outperform” rating in a research report issued on Monday, The Fly reports. The brokerage presently has a $98.00 price objective on the medical instruments supplier’s stock. Cowen’s price objective suggests a potential upside of 21.11% from the company’s previous close.

BAX has been the topic of a number of other research reports. SVB Leerink reissued a “buy” rating on shares of Baxter International in a report on Sunday, September 5th. Piper Sandler reduced their price target on shares of Baxter International from $85.00 to $82.00 and set a “neutral” rating for the company in a research report on Thursday, July 29th. Stifel Nicolaus decreased their price objective on shares of Baxter International from $95.00 to $90.00 and set a “buy” rating for the company in a research note on Thursday, July 29th. Barclays upgraded Baxter International from an “equal weight” rating to an “overweight” rating and lifted their target price for the stock from $93.00 to $100.00 in a research report on Friday, September 3rd. Finally, KeyCorp lowered their price objective on Baxter International from $94.00 to $92.00 and set an “overweight” rating on the stock in a report on Monday, August 2nd. Four investment analysts have rated the stock with a hold rating and ten have issued a buy rating to the company’s stock. According to MarketBeat, Baxter International currently has an average rating of “Buy” and an average target price of $91.08. Read more …

 


Canadian Western Bank (TSE:CWB) was upgraded by equities research analysts at Raymond James from a "market perform" rating to an "outperform" rating in a research note issued on Monday, Price Targets.com reports. The firm currently has a C$41.00 price objective on the stock, up from their previous price objective of C$39.25. Raymond James' price target indicates a potential upside of 13.04% from the company's previous close.

CWB has been the subject of a number of other research reports. National Bankshares upped their target price on shares of Canadian Western Bank from C$40.00 to C$41.00 and gave the stock a "sector perform" rating in a research report on Monday, August 30th. Barclays upgraded shares of Canadian Western Bank from a "neutral" rating to an "overweight" rating and set a C$37.00 price objective for the company in a research report on Friday, May 28th. BMO Capital Markets increased their price objective on shares of Canadian Western Bank from C$37.00 to C$41.00 and gave the company a "market perform" rating in a research report on Monday, May 31st. Credit Suisse Group increased their target price on shares of Canadian Western Bank to C$45.00 and gave the company a "sector peform" rating in a research note on Wednesday, September 1st. Finally, CIBC increased their target price on shares of Canadian Western Bank from C$42.00 to C$44.00 and gave the company an "outperform" rating in a research note on Monday, August 30th. Four investment analysts have rated the stock with a hold rating and five have given a buy rating to the company's stock. According to data from MarketBeat.com, Canadian Western Bank presently has a consensus rating of "Buy" and an average target price of C$41.17. Read more …

 

 


Apple (NASDAQ:AAPL) was upgraded by analysts at Oppenheimer to an “outperform” rating in a note issued to investors on Wednesday, The Fly reports. The brokerage currently has a $165.00 price target on the iPhone maker’s stock. Oppenheimer’s target price would indicate a potential upside of 11.40% from the stock’s current price.

AAPL has been the subject of a number of other reports. Jefferies Financial Group started coverage on shares of Apple in a research note on Monday. They issued a “buy” rating and a $175.00 price objective for the company. Deutsche Bank Aktiengesellschaft lifted their price objective on shares of Apple from $165.00 to $175.00 and gave the stock a “buy” rating in a report on Wednesday, July 28th. Sanford C. Bernstein reaffirmed a “hold” rating and set a $132.00 price objective on shares of Apple in a report on Tuesday, August 10th. Barclays lifted their price objective on shares of Apple from $134.00 to $142.00 and gave the stock an “equal weight” rating in a report on Wednesday, July 28th. They noted that the move was a valuation call. Finally, Morgan Stanley lifted their target price on shares of Apple from $166.00 to $168.00 and gave the stock an “overweight” rating in a research report on Wednesday, July 28th. One analyst has rated the stock with a sell rating, six have assigned a hold rating and twenty-six have assigned a buy rating to the stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Buy” and a consensus target price of $160.88. Read more …

7 Great Dividend Stocks To Buy In September For Insulation from Volatility

 

These dividend stocks could appeal to risk-averse investors in September

 


Equities have surged to lofty valuations in the past year and a half. The S&P 500 index jumped from a low of around 2,200 in March 2020 to more than 4,400 in about 350 trading days, the quickest doubling of the index in stock market history.

 

However, the big rally is likely to come to an end. As investors become increasingly concerned about an inevitable correction around the corner, September looks to be the right time to reallocate towards reliable dividend stocks.

 

Dividend shares add stability to long-term portfolios and allow income seekers to collect regular cash payments regardless of market volatility. In fact, metrics highlight that dividend stocks have vastly outpaced their non-dividend-paying peers over the long run.

 

Recent research suggests that, “From 1930–2020, dividend income’s contribution to the total return of the S&P 500 Index averaged 41%… Today, investors continue to place a high premium on the more tangible and immediate returns that dividends provide.”

 

JPMorgan Chase (NYSE:JPM) also cites, “… companies that initiated and grew their dividends posted average annualized total returns of about 9.5% from 1972 through the end of 2012 compared with 1.6% for non dividend-paying stocks.”

 

 

As we move forward in September, these seven dividend stocks offer the perfect combination of value, income, and growth potential:

 

Continue reading …

 

Home Depot Inc: Delivering Both Income & Growth to Investors

 

Why Home Depot Stock Could Be Special

 



In an era when e-commerce stocks are all the rage, who would have thought that a company known for its big box stores would see its share price shoot through the roof?

 

But it is happening: shares of Home Depot Inc (NYSE:HD) have surged by 138% over the past five years. And that figure doesn’t include the additional returns that shareholders have collected through the company’s rising dividend payments.

 

Home Depot is the largest home improvement retailer in the world. The company was founded in 1978 and opened its first two stores in June 1979. Today, it operates approximately 2,300 stores in all 50 U.S. states, the District of Columbia, Puerto Rico, the U.S. Virgin Islands, Guam, all 10 Canadian provinces, and Mexico.

 

In its current configuration, a typical Home Depot store averages at about 105,000 square feet of indoor retail space, which dwarfs most of its competitors. But we know that brick-and-mortar retailers have suffered from the rise of the e-commerce industry. So, how has Home Depot’s business been lately?

 

Surprisingly well. In the company’s fiscal year 2020, which ended January 31, 2021, it generated $132.1 billion in total sales, representing a 19.9% increase year-over-year.

 

 

The company’s comparable sales, a critical measure of a retailer’s performance, increased by 19.7% in fiscal 2020. Notably, its comparable sales in the U.S. rose by 20.6%.

 

Continue reading …

 

Most Significant Insider Trades: Week of September 6, 2021

 



Disposals:

 


CVS Health Co. (NYSE:CVS) EVP Troyen A. Brennan sold 2,625 shares of the firm’s stock in a transaction dated Thursday, September 2nd. The shares were sold at an average price of $87.00, for a total value of $228,375.00. Following the transaction, the executive vice president now owns 140,201 shares of the company’s stock, valued at $12,197,487. The sale was disclosed in a document filed with the SEC, which is available through the SEC website.

CVS Health stock traded down $0.89 during midday trading on Tuesday, reaching $86.58. The stock had a trading volume of 4,617,848 shares, compared to its average volume of 6,502,718. CVS Health Co. has a twelve month low of $55.36 and a twelve month high of $90.61. The company has a debt-to-equity ratio of 0.81, a current ratio of 0.95 and a quick ratio of 0.67. The firm has a market cap of $114.25 billion, a price-to-earnings ratio of 15.89, a PEG ratio of 1.75 and a beta of 0.83. The firm’s fifty day simple moving average is $83.38 and its two-hundred day simple moving average is $80.50. Read more …

 


Albemarle Co. (NYSE:ALB) EVP Karen G. Narwold sold 1,337 shares of the stock in a transaction that occurred on Wednesday, September 8th. The shares were sold at an average price of $243.75, for a total transaction of $325,893.75. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link.

Karen G. Narwold also recently made the following trade(s):

On Monday, August 9th, Karen G. Narwold sold 1,338 shares of Albemarle stock. The stock was sold at an average price of $224.71, for a total transaction of $300,661.98.

Albemarle stock traded up $0.50 during trading on Wednesday, reaching $239.28. The company had a trading volume of 1,183,337 shares, compared to its average volume of 1,395,791. The firm’s 50-day simple moving average is $207.73 and its 200 day simple moving average is $175.58. Albemarle Co. has a 1-year low of $79.06 and a 1-year high of $248.71. The firm has a market capitalization of $27.98 billion, a PE ratio of 38.78, a price-to-earnings-growth ratio of 4.53 and a beta of 1.57. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.44 and a current ratio of 2.18. Read more …

 


American Tower Co. (REIT) (NYSE:AMT) Director David E. Sharbutt sold 739 shares of the business’s stock in a transaction dated Friday, September 3rd. The shares were sold at an average price of $300.71, for a total transaction of $222,224.69. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link.

Shares of AMT stock traded up $4.40 during trading hours on Wednesday, hitting $303.62. The company’s stock had a trading volume of 1,508,496 shares, compared to its average volume of 1,870,768. The company has a 50 day moving average of $283.81 and a 200 day moving average of $257.91. The stock has a market cap of $138.19 billion, a PE ratio of 60.86, a price-to-earnings-growth ratio of 2.13 and a beta of 0.24. The company has a current ratio of 0.77, a quick ratio of 0.77 and a debt-to-equity ratio of 4.83. American Tower Co. has a 12-month low of $197.50 and a 12-month high of $303.72. Read more …

 

 


Chubb Limited (NYSE:CB) EVP Joseph F. Wayland sold 5,277 shares of the company’s stock in a transaction on Tuesday, September 7th. The shares were sold at an average price of $181.92, for a total transaction of $959,991.84. The transaction was disclosed in a filing with the SEC, which is available at this link.

Shares of NYSE CB traded up $0.55 during trading on Wednesday, reaching $182.32. 47,006 shares of the company traded hands, compared to its average volume of 1,729,610. The firm has a 50 day simple moving average of $173.63 and a 200-day simple moving average of $168.64. The company has a quick ratio of 0.32, a current ratio of 0.32 and a debt-to-equity ratio of 0.25. The stock has a market capitalization of $79.99 billion, a PE ratio of 10.04, a P/E/G ratio of 1.47 and a beta of 0.73. Chubb Limited has a 52-week low of $111.93 and a 52-week high of $187.90. Read more …

Notable Analyst Upgrades and Downgrades for Week of September 6, 2021



 

Upgrades:

 


Bank of Montreal (NYSE:BMO) (TSE:BMO) was upgraded by analysts at Barclays from an "underweight" rating to an "equal weight" rating in a research note issued to investors on Tuesday, Briefing.com reports.

Other analysts have also issued research reports about the stock. Credit Suisse Group raised their price objective on shares of Bank of Montreal from $138.00 to $144.00 and gave the stock an "outperform" rating in a report on Wednesday, August 25th. CIBC raised their price objective on shares of Bank of Montreal from $139.00 to $148.00 and gave the stock an "outperformer" rating in a report on Wednesday, August 25th. Canaccord Genuity raised their price objective on shares of Bank of Montreal from C$143.00 to C$149.00 and gave the stock a "buy" rating in a report on Wednesday, August 25th. BMO Capital Markets raised their price objective on shares of Bank of Montreal from C$150.00 to C$152.00 and gave the stock a "buy" rating in a report on Wednesday, August 25th. Finally, Desjardins raised their price objective on shares of Bank of Montreal from C$133.00 to C$138.00 and gave the stock a "hold" rating in a report on Thursday, August 26th. Four analysts have rated the stock with a hold rating and seven have given a buy rating to the company's stock. According to data from MarketBeat, the company currently has a consensus rating of "Buy" and a consensus target price of $142.27. Read more …

 


The Southern (NYSE:SO) was upgraded by analysts at Guggenheim from a "neutral" rating to a "buy" rating in a research note issued on Tuesday, The Fly reports.

Other analysts also recently issued reports about the company. Wells Fargo & Company reaffirmed a "buy" rating on shares of The Southern in a report on Monday, August 2nd. Morgan Stanley boosted their target price on The Southern from $60.00 to $64.00 and gave the company an "underweight" rating in a report on Thursday, August 19th. Barclays boosted their target price on The Southern from $70.00 to $76.00 and gave the company an "overweight" rating in a report on Tuesday, May 25th. Credit Suisse Group reissued a "buy" rating on shares of The Southern in a report on Wednesday, May 19th. Finally, Mizuho boosted their target price on The Southern from $57.00 to $60.00 and gave the company an "underperform" rating in a report on Monday, August 30th. Three analysts have rated the stock with a sell rating, one has issued a hold rating and nine have assigned a buy rating to the company's stock. Based on data from MarketBeat, the company has an average rating of "Hold" and an average price target of $68.42. Read more …

 


The Toronto-Dominion Bank (NYSE:TD) (TSE:TD) was upgraded by stock analysts at Barclays from an “equal weight” rating to an “overweight” rating in a note issued to investors on Tuesday, The Fly reports.

TD has been the topic of several other reports. Zacks Investment Research cut The Toronto-Dominion Bank from a “hold” rating to a “sell” rating in a research note on Tuesday. BMO Capital Markets reduced their price objective on The Toronto-Dominion Bank from C$96.00 to C$94.00 and set a “market perform” rating on the stock in a research note on Friday, August 27th. Finally, Scotiabank reduced their price objective on The Toronto-Dominion Bank from C$95.00 to C$94.00 in a research note on Tuesday, August 17th. Four analysts have rated the stock with a sell rating, four have given a hold rating and two have assigned a buy rating to the company. Based on data from MarketBeat, the stock presently has an average rating of “Hold” and a consensus target price of $80.60. Read more …

 

 


Ventas (NYSE:VTR) was upgraded by Deutsche Bank Aktiengesellschaft from a "hold" rating to a "buy" rating in a research report issued on Tuesday, The Fly reports.

Several other equities analysts also recently commented on the stock. Royal Bank of Canada upped their price target on shares of Ventas from $62.00 to $65.00 and gave the company an "outperform" rating in a report on Wednesday, June 30th. Wolfe Research began coverage on shares of Ventas in a research note on Monday, June 14th. They issued an "outperform" rating and a $71.00 target price on the stock. BMO Capital Markets upgraded shares of Ventas from an "underperform" rating to a "market perform" rating and set a $60.00 target price on the stock in a research note on Thursday, August 26th. Robert W. Baird upgraded shares of Ventas from a "neutral" rating to an "outperform" rating and set a $58.00 target price on the stock in a research note on Thursday, May 13th. Finally, Scotiabank upped their target price on shares of Ventas from $61.00 to $63.00 and gave the stock a "sector perform" rating in a research note on Thursday, July 1st. Eight equities research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company. Based on data from MarketBeat, the stock has a consensus rating of "Hold" and a consensus price target of $58.41. Read more …